Smoore, a company in the e-cigarette industry, stated that there is a need to find opportunities to reduce the nicotine content in e-cigarettes to a non-addictive level.
The Smoore scientific project, a collaboration between the Shenzhen Institute of Advanced Technology (SIAT) and Neera (Shenzhen Neera Neuroplasticity Laboratory), is set to investigate the secretion and metabolic processes in the brains of animals. Using the information obtained, the aim is to replicate human nicotine dependency.
As part of an experiment, a laboratory sponsored by Nobel Prize winner Dr. Erwin Neera will subject test subjects to exposure of aerosols from electronic cigarettes and traditional combustible tobacco. Researchers will monitor nicotine absorption processes in various organs. The ultimate goal of the study is to reduce the nicotine content in Smoore products to levels that will not cause dependence in smokers.
It is expected that the results of scientific research will also reduce the impact of electronic cigarettes on health, and there are plans to optimize nicotine delivery mechanisms. Smoore will submit preliminary results by the end of this year. The first report will describe the differences in the effects of nicotine on the brain between electronic cigarettes and traditional cigarettes.
Statement
This article is compiled from third-party information and is only intended for industry exchange and learning.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The compilation of this article is only intended for industry-related communication and research.
Due to limitations in the translation ability, the translated article may not fully convey the same meaning as the original. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government's position on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and stances.
Copyright for the compiled information belongs to the original media and author. If there is any copyright infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
